A-MATRX Micrograft
Human Placental Tissue Matrix in a Conformable Micrograft Format
A-MATRX Micrograft is a dehydrated human placental tissue matrix designed for targeted placement, adaptable handling, and site-specific tissue coverage in surgical and wound management settings.
Supplied in a dry micrograft configuration, A-MATRX gives clinicians a familiar particulate-style workflow while preserving the clinical purpose of a human tissue matrix: to provide structural tissue coverage where the clinician determines additional coverage is appropriate.
Same trusted tissue platform. More precise placement. A new matrix identity.
Not Just a Powder. A Placental Tissue Matrix.
Many particulate products used in surgical and wound care environments are based on collagen, animal-derived extracellular matrix, synthetic materials, or hemostatic agents. These products have helped establish clinician familiarity with powder and particulate workflows.
A-MATRX is different.
A-MATRX is derived from human placental tissue and supplied as a dehydrated tissue matrix micrograft. Its purpose is not to control bleeding or act as a collagen-only dressing. Its purpose is to provide targeted human tissue matrix coverage, consistent with the Instructions for Use and clinician judgment.
- 01
Familiarity of particulate-style application
- 02
Clinical utility of conformable placement
- 03
Structural value of human placental tissue matrix
- 04
Workflow advantages of a dry, ready-to-use format
Placental Tissue Matrix, Refined for Targeted Placement
A-MATRX Micrograft is produced from dehydrated human placental tissue and supplied in a dry, particulate micrograft format. It is designed to support clinician-directed placement across complex, irregular, or anatomically nuanced sites where flat sheet placement may not be ideal.
The micrograft configuration allows clinicians to distribute, layer, and contour the tissue matrix according to the needs of the site and the procedural plan.
“Where a sheet provides broad coverage, A-MATRX provides targeted matrix placement.”
Because Surgical Sites Are Rarely Flat
Anatomy does not always present as a clean rectangle. Surgical and wound sites can be curved, uneven, deep, narrow, irregular, or difficult to cover with a traditional sheet configuration.
A-MATRX Micrograft was developed for these moments. Its dry micrograft format supports controlled placement into areas where contour, contact, and coverage are important. Clinicians can apply the matrix in a way that works with the site instead of forcing the site to work around the product.
Complex contours
Irregular tissue planes
Small or focused areas of coverage
Sites where sheet trimming may be inefficient
Procedures requiring targeted tissue matrix placement
Clinical workflows that benefit from ready-to-use handling
Built From the EvoPatch Platform
Same tissue platform. New geometry.
A-MATRX Micrograft is built from the same tissue platform as EvoPatch, now presented in a micrograft configuration for more targeted placement.
The result is a product that maintains the identity of a human placental tissue matrix while giving clinicians a more flexible format for complex sites.
Sheet Format
Broad tissue coverage.
- Broad coverage areas
- Uniform sheet geometry
- Familiar sheet handling
Micrograft Format
Targeted, conformable placement.
- Complex or irregular anatomy
- Distribute, layer, contour
- Targeted matrix placement
When broad coverage is needed, a sheet format may be appropriate. When targeted placement and contouring are the priority, A-MATRX gives clinicians another option.
Surgical Teams Already Understand Particulate Formats
Across the operating room and wound care environment, clinicians are familiar with powder, particulate, and matrix-based products. Some are used as adjunctive hemostats. Some are collagen-based wound products. Others are extracellular matrix particulates designed to improve contact with complex or irregular wound beds.
A-MATRX enters this familiar handling universe with a distinct identity: a human placental tissue matrix supplied in a micrograft format for targeted coverage.
Hemostatic powders
Designed for bleeding control.
Collagen powders
Commonly used as collagen-based wound dressings.
Animal-derived ECM particulates
Often selected for complex wound-bed contact.
A-MATRX Micrograft
Human placental tissue matrix for targeted structural tissue coverage.
Note: A-MATRX is not intended for use as a hemostatic agent.
A Format Designed Around the Site
A-MATRX Micrograft may be considered when the clinician determines that additional tissue matrix coverage is appropriate and when the site may benefit from a conformable, targeted format.
Use of A-MATRX should always be based on clinician judgment, patient presentation, procedural goals, and the product Instructions for Use.
Precision Matrix Coverage, Ready When Needed
Human placental tissue matrix
Derived from donated human placental tissue and processed into a dehydrated matrix format.
Micrograft configuration
Designed for targeted placement, distribution, layering, and contouring at the site.
Dry application
Supplied in a dry format to support efficient surgical and wound management workflows.
Conformable handling
Can be applied across complex or irregular sites where sheet placement may be less practical.
Ready to use
Designed for straightforward clinical handling according to the Instructions for Use.
Ambient storage
No refrigeration required.
Multiple configurations
Available in multiple sizes to support different site requirements and procedural preferences.
Available Configurations
Sterile. Dehydrated. Ready for use according to the Instructions for Use.
Sterile. Dehydrated. Ready for use according to the Instructions for Use.
Sterile. Dehydrated. Ready for use according to the Instructions for Use.
Sterile. Dehydrated. Ready for use according to the Instructions for Use.
Simple. Targeted. Controlled.
Prepare
Open and prepare the product according to sterile technique and the Instructions for Use.
Place
Apply the micrograft matrix to the area where the clinician determines tissue coverage is appropriate.
Contour
Distribute, layer, or contour the micrograft based on the surgical site, wound geometry, and clinician technique.
Proceed
Continue with the planned surgical or wound management protocol.
Designed for Real Clinical Logistics
A-MATRX Micrograft supports practical inventory and procedural readiness.
- No refrigeration required
- Ambient temperature storage
- Three-year shelf life
- Compact packaging
- Ready-to-use format
- Multiple size options
- Efficient product selection for different site needs
Frequently Asked Questions
Regulatory and Use Information
A-MATRX Micrograft is a human cells, tissues, and cellular and tissue-based product, or HCT/P, regulated under Section 361 of the Public Health Service Act and 21 CFR Part 1271.
Use is limited to homologous use and should be consistent with the product Instructions for Use, applicable labeling, clinician judgment, and institutional protocol.
A-MATRX Micrograft is not intended for use as a hemostatic agent and should not be used as a substitute for meticulous surgical technique or conventional methods of hemostasis.
Bring Placental Matrix Coverage Into Focus
A-MATRX Micrograft gives clinicians a human placental tissue matrix option in a dry, conformable micrograft format.
For complex sites, irregular anatomy, and targeted coverage needs, A-MATRX offers a refined alternative to sheet-only placement.
Request Product Information
Complete the form and an Evologics representative will follow up with product materials, sizing details, and next steps.
Regulated under Section 361 of the Public Health Service Act and 21 CFR Part 1271.
Same trusted platform. New micrograft geometry.